Get the Stockscreener App
4.23
4.30%
-0.19
Clene Inc stock is traded at $4.23, with a volume of 65,048.
It is down -4.30% in the last 24 hours and up +64.59% over the past month.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
See More
Previous Close:
$4.42
Open:
$4.49
24h Volume:
65,048
Relative Volume:
0.73
Market Cap:
$38.27M
Revenue:
$442.00K
Net Income/Loss:
$-30.46M
P/E Ratio:
-0.9484
EPS:
-4.46
Net Cash Flow:
$-27.47M
1W Performance:
-0.70%
1M Performance:
+64.59%
6M Performance:
-2.98%
1Y Performance:
-43.39%
1-Day Range:
$4.16
$4.49
1-Week Range:
$4.01
$4.62
52-Week Range:
$2.2801
$8.396
Clene Inc Stock (CLNN) Company Profile
Name
Clene Inc
Sector
Industry
Phone
801-676-9695
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
4.23 | 38.27M | 442.00K | -30.46M | -27.47M | -4.46 |
|
KHC
Kraft Heinz Co
|
25.75 | 31.47B | 25.43B | 2.66B | 3.03B | 2.19 |
|
JBS
Jbs N V
|
14.00 | 30.77B | 88.95B | 2.16B | 374.50M | 0.9748 |
|
GIS
General Mills Inc
|
53.08 | 29.84B | 19.64B | 2.56B | 2.48B | 4.55 |
|
K
Kellanova
|
80.23 | 28.25B | 12.63B | 1.38B | 863.00M | 3.96 |
|
MKC
Mccormick Co Inc
|
72.96 | 20.27B | 6.68B | 792.60M | 774.40M | 2.94 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-22 | Initiated | H.C. Wainwright | Buy |
| May-02-22 | Initiated | Canaccord Genuity | Buy |
| Sep-28-21 | Initiated | Oppenheimer | Outperform |
Clene Inc Stock (CLNN) Latest News
Clene Regains Nasdaq Compliance as of June 2025 - TipRanks
Top Nanotechnology Stocks Worth WatchingJune 17th - MarketBeat
Best Nanotechnology Stocks To Keep An Eye OnJune 15th - MarketBeat
Nanotechnology Stocks To Watch NowJune 14th - MarketBeat
Best Nanotechnology Stocks To Add to Your WatchlistJune 16th - MarketBeat
Best Nanotechnology Stocks To Follow Now – June 13th - Defense World
Clene Inc. (NASDAQ:CLNN) Receives $40.00 Average Target Price from Analysts - Defense World
Promising Nanotechnology Stocks To ResearchJune 11th - MarketBeat
Nanotechnology Stocks To ResearchJune 8th - MarketBeat
Clene (NASDAQ:CLNN) Trading Down 0.7% – Should You Sell? - Defense World
Clene Inc. CEO to Share Company Updates at Investor Summit Virtual - citybuzz -
Clene Inc. Chief Executive Officer Rob Etherington to Present at - GuruFocus
Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025 | CLNN Stock News - GuruFocus
Clene CEO Rob Etherington Set to Reveal Company Updates at Investor Summit Virtual Conference - Stock Titan
Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025 - The Globe and Mail
Clene Inc. (CLNN) Executives to Host Meeting with Maxim | CLNN S - GuruFocus
Clene management to meet with Maxim - TipRanks
Nanomedicines Market Booming Worldwide: Growth Trends, - openPR.com
Clene Inc. shareholder General Resonance sells $2,472 in stock - Investing.com
Best Nanotechnology Stocks To Follow Today – May 31st - Defense World
Clene Inc. shareholder General Resonance sells $2,472 in stock By Investing.com - Investing.com UK
Clene Inc.: General Resonance LLC sells $1,148 in common stock By Investing.com - Investing.com Nigeria
Clene Inc.: General Resonance LLC sells $1,148 in common stock - Investing.com
Clene inc. sees $1,089 stock sale by major shareholder - Investing.com South Africa
Clene Approves Stock Plan Amendment at Annual Meeting - TipRanks
Clene stock touches 52-week low at $2.5 amid market challenges By Investing.com - Investing.com South Africa
Clene stock touches 52-week low at $2.5 amid market challenges - Investing.com Australia
Brokerages Set Clene Inc. (NASDAQ:CLNN) Target Price at $40.00 - Defense World
Clene eyeing regulatory submission for CNM-Au8 in ALS by year’s end - ALS News Today
Clene Inc. (CLNN) Reports Q1 Loss, Lags Revenue Estimates - MSN
HC Wainwright Issues Positive Forecast for Clene Earnings - Defense World
Roth Capital Has Optimistic Outlook of Clene Q2 Earnings - Defense World
Benchmark Lowers Clene (NASDAQ:CLNN) Price Target to $33.00 - Defense World
D. Boral Capital Reaffirms Buy Rating for Clene (NASDAQ:CLNN) - Defense World
Clene Inc. Reports Reduced Losses Amid Strategic Cost-Saving Measures - TipRanks
Promising Nanotechnology Stocks To Watch Now – May 7th - The AM Reporter
Clene Inc. Advances CNM-Au8 Treatment for ALS, Reports Promising Q1 Results - citybuzz -
Clene Inc. Advances CNM-Au8 Toward Potential Accelerated Approval for ALS - citybuzz -
Clene’s Strategic Financial Management and Promising Clinical Developments Drive Buy Rating - TipRanks
Clene (CLNN) Maintains Buy Rating Despite Price Target Reduction | CLNN Stock News - GuruFocus
Clene (CLNN) Stock Rating and Price Target Maintained at Buy | C - GuruFocus
Renaissance Technologies LLC Invests $96,000 in Clene Inc. (NASDAQ:CLNN) - Defense World
Clene Inc. to Showcase Neurodegenerative Research at D. Boral Capital Global Conference - citybuzz -
Clene (CLNN) Reports Decline in Cash Reserves | CLNN Stock News - GuruFocus
Clene Faces Nasdaq Delisting Risk Amid Regulatory Pursuits - TipRanks
Clene (CLNN) Exceeds Revenue Expectations and Advances ALS Research | CLNN Stock News - GuruFocus
Clene Reports First Quarter 2025 Financial Results and Recent Operating Highlights - The Manila Times
Clene Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference | CLNN Stock News - GuruFocus
Clene Inc. SEC 10-Q Report - TradingView
Clene Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference - The Kingston Whig Standard
Geode Capital Management LLC Grows Stake in Clene Inc. (NASDAQ:CLNN) - Defense World
Clene Inc Stock (CLNN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):